Statement: Agatha had her 53rd birthday last week, she has a histologically confirmed adenocarcinoma of the breast, with no evidence of metastatic disease. Agatha is of white british origin. she is eligible for the primary trial but not the secondary trial, due to her age.
Primary_evidence: Inclusion Criteria:   female patients 18-70 years of age;   adenocarcinoma of the breast;   previous invasive breast cancer if diagnosed >5 years before entering study;   no evidence of metastatic disease. Exclusion Criteria:   history of severe hypersensitivity reaction to Taxotere;   previous treatment with anthracycline, anthracenedione (mitoxantrone), or taxane;   treatment with fluoropyrimidine (5-fluorouracil) within the last 5 years.
Secondary_evidence: Inclusion Criteria:   Age 52-75 years old;   Identification as Latina/Hispanic/Chicana female;   Residence in Pilsen, Little Village, East Side or South Chicago;   No history of health volunteerism;   No history of breast cancer; and   Lack of a mammogram within the last two years Exclusion Criteria:   Not meeting all inclusion criteria;   Women will be excluded if they participated in formative focus groups